BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$0.94−0.05 (-5.27%)
Close on Nov 18, 2026Market cap $7.11MP/E –Yield –
BioVie operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BioVie's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.02M. For fiscal 2026 it was -$19.02M. The highest annual figure on record is -$2.51K in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$19.02M | – |
| FY2025 | Jun 30, 2025 | -$19.03M | – |
| FY2024 | Jun 30, 2024 | -$27.95M | – |
| FY2023 | Jun 30, 2023 | -$40.25M | – |
| FY2022 | Jun 30, 2022 | -$18.99M | – |
| FY2021 | Jun 30, 2021 | -$10.45M | – |
| FY2020 | Jun 30, 2020 | -$1.63M | – |
| FY2019 | Jun 30, 2019 | -$2.50M | – |
| FY2018 | Jun 30, 2018 | -$621.34K | – |
| FY2017 | Jun 30, 2017 | -$623.62K | – |
| FY2016 | Jun 30, 2016 | -$153.63K | – |
| FY2015 | Jun 30, 2015 | -$65.38K | – |
| FY2014 | Jun 30, 2014 | -$172.83K | – |
| FY2013 | Jun 30, 2013 | -$2.51K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$4.12M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$7.44M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$4.44M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$3.02M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$5.61M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$1.25M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$8.58M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$3.58M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$4.01M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$5.85M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$5.91M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$12.18M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$11.29M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$11.74M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$8.01M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$9.22M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$5.87M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$5.88M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$4.71M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$2.53M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$7.01M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$1.04M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$1.32M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$1.08M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$360.02K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$401.39K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$275.90K | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$590.91K | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$631.69K | – |
| Q1 FY2019CQ3 2018 | Dec 31, 2018 | -$1.21M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$209.28K | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$48.75K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$159.88K | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$203.44K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$125.17K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$268.72K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$101.71K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$128.01K | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$119.39K | – |
See a number that looks wrong?